Abstract
Drug discovery has undergone a significant change since its early days. The speedy evolution of scientific discoveries and accompanying social awareness of what constitutes the process of manufacturing and testing of new medicines have made a huge impact on their production and approval for human usage. We are now realizing that the industry pipeline is narrowing more and as a consequence the amount of novel successful product that gets to the market is less than 70% of what it used to be 20 years ago. In this chapter, we analyze some of the reasons behind this realization. The chapter describes the new processes and regulations behind the production and clinical testing of new pharmaceutical products, with a focus in the latest harmonization efforts in the United States and Europe which are becoming worldwide standards.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.